[1]Furet;Batzl;Bhatnagar;Francotte;Rihs;Lang[JournalofMedicinalChemistry,1993,vol.36,#10,p.1393-1400]
[1]Furet;Batzl;Bhatnagar;Francotte;Rihs;Lang[JournalofMedicinalChemistry,1993,vol.36,#10,p.1393-1400]
[2]CurrentPatentAssignee:DAMIANPHARMAAG;DAMIANPHARMA-WO2018/78049,2018,A1
[3]CurrentPatentAssignee:DAMIANPHARMA-WO2019/211394,2019,A1
[4]CurrentPatentAssignee:DAMIANPHARMA-WO2019/211394,2019,A1
[1]Furet;Batzl;Bhatnagar;Francotte;Rihs;Lang[JournalofMedicinalChemistry,1993,vol.36,#10,p.1393-1400]
[1]Browne,L.J.;Gude,C.;Rodriguez,H.;Steele,R.E.[JournalofMedicinalChemistry,1991,vol.34,#2,p.725-736]
[1]Browne,L.J.;Gude,C.;Rodriguez,H.;Steele,R.E.[JournalofMedicinalChemistry,1991,vol.34,#2,p.725-736]
Title: Browne LJ, et al. Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease. J Med Chem. 1991 Feb;34(2):725-36.
Title: Gunson DE, et al. Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor. Br J Cancer. 1995 Jul;72(1):72-5.
Title: Morales-Montor J, et al. Inhibition of p-450 aromatase prevents feminisation and induces protection during cysticercosis. Int J Parasitol. 2002 Oct;32(11):1379-87.
